These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12535467)

  • 1. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2003; (1):CD003280. PubMed ID: 12535467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003280. PubMed ID: 15495046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Swan AV; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003280. PubMed ID: 21069674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2013 Jun; (6):CD003280. PubMed ID: 23771584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
    Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
    Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mehndiratta MM; Hughes RA; Agarwal P
    Cochrane Database Syst Rev; 2004; (3):CD003906. PubMed ID: 15266507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mehndiratta MM; Hughes RA
    Cochrane Database Syst Rev; 2001; (3):CD002062. PubMed ID: 11687011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Mehndiratta MM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD002062. PubMed ID: 22895925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mehndiratta MM; Hughes RA
    Cochrane Database Syst Rev; 2002; (1):CD002062. PubMed ID: 11869620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA
    Drugs; 2003; 63(3):275-87. PubMed ID: 12534332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Mehndiratta MM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD002062. PubMed ID: 25561247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.
    Umapathi T; Hughes RA; Nobile-Orazio E; Léger JM
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003217. PubMed ID: 16034892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive treatment for multifocal motor neuropathy.
    Umapathi T; Hughes RA; Nobile-Orazio E; Léger JM
    Cochrane Database Syst Rev; 2002; (2):CD003217. PubMed ID: 12076474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Van Schaik IN; Winer JB; De Haan R; Vermeulen M
    Cochrane Database Syst Rev; 2002; (2):CD001797. PubMed ID: 12076423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mehndiratta MM; Hughes RA
    Cochrane Database Syst Rev; 2012 Sep; (9):CD003906. PubMed ID: 22972066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive agents for myasthenia gravis.
    Hart IK; Sathasivam S; Sharshar T
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005224. PubMed ID: 17943844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
    Bright RJ; Wilkinson J; Coventry BJ
    BMC Neurol; 2014 Feb; 14():26. PubMed ID: 24507546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.